Two Point Capital Management Inc. Has $2.91 Million Stake in Amdocs Limited (NASDAQ:DOX)

Two Point Capital Management Inc. increased its position in Amdocs Limited (NASDAQ:DOX) by 0.8% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 33,116 shares of the technology company’s stock after purchasing an additional 260 shares during the period. Amdocs comprises about 1.3% of Two Point Capital Management Inc.’s investment portfolio, making the stock its 21st biggest holding. Two Point Capital Management Inc.’s holdings in Amdocs were worth $2,911,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. New York State Teachers Retirement System bought a new position in shares of Amdocs during the 4th quarter valued at $930,000. Diversified Trust Co bought a new position in shares of Amdocs during the 4th quarter valued at $3,957,000. Wedge Capital Management L L P NC raised its holdings in shares of Amdocs by 9.3% during the 4th quarter. Wedge Capital Management L L P NC now owns 917,808 shares of the technology company’s stock valued at $80,666,000 after purchasing an additional 77,833 shares in the last quarter. Legato Capital Management LLC bought a new position in shares of Amdocs during the 4th quarter valued at $2,260,000. Finally, Xponance Inc. raised its holdings in shares of Amdocs by 8.4% during the 3rd quarter. Xponance Inc. now owns 4,469 shares of the technology company’s stock valued at $378,000 after purchasing an additional 348 shares in the last quarter. Institutional investors and hedge funds own 92.02% of the company’s stock.

Amdocs Stock Down 0.7 %

Shares of Amdocs stock traded down $0.62 on Friday, hitting $85.02. The company had a trading volume of 338,051 shares, compared to its average volume of 646,009. The firm has a market capitalization of $9.99 billion, a P/E ratio of 18.25, a P/E/G ratio of 1.41 and a beta of 0.69. Amdocs Limited has a twelve month low of $78.38 and a twelve month high of $99.75. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.29 and a quick ratio of 1.29. The stock has a 50-day moving average of $89.75 and a 200-day moving average of $87.31.

Amdocs (NASDAQ:DOX) last announced its quarterly earnings data on Tuesday, February 6th. The technology company reported $1.56 EPS for the quarter, topping analysts’ consensus estimates of $1.40 by $0.16. Amdocs had a net margin of 11.30% and a return on equity of 17.79%. The business had revenue of $1.25 billion for the quarter, compared to analyst estimates of $1.24 billion. During the same quarter in the previous year, the firm posted $1.33 earnings per share. The firm’s revenue for the quarter was up 5.0% on a year-over-year basis. Research analysts predict that Amdocs Limited will post 5.87 earnings per share for the current year.

Amdocs Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 26th. Stockholders of record on Friday, March 29th will be given a $0.479 dividend. The ex-dividend date is Wednesday, March 27th. This is a positive change from Amdocs’s previous quarterly dividend of $0.44. This represents a $1.92 annualized dividend and a dividend yield of 2.25%. Amdocs’s dividend payout ratio is presently 41.11%.

Analysts Set New Price Targets

Several analysts have issued reports on DOX shares. Barclays raised their price target on shares of Amdocs from $105.00 to $115.00 and gave the stock an “overweight” rating in a research report on Thursday, February 8th. StockNews.com lowered shares of Amdocs from a “strong-buy” rating to a “buy” rating in a research report on Friday, March 15th. Finally, Citigroup lifted their target price on shares of Amdocs from $96.00 to $104.00 and gave the company a “buy” rating in a research report on Wednesday, January 17th. Five research analysts have rated the stock with a buy rating, According to MarketBeat, the stock currently has an average rating of “Buy” and an average price target of $108.60.

About Amdocs

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.